{"id":719821,"date":"2026-06-22T20:29:18","date_gmt":"2026-06-22T20:29:18","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/719821\/"},"modified":"2026-06-22T20:29:18","modified_gmt":"2026-06-22T20:29:18","slug":"fda-pilot-program-aims-to-speed-up-early-stage-clinical-trials","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/719821\/","title":{"rendered":"FDA pilot program aims to speed up early-stage clinical trials"},"content":{"rendered":"<p class=\"author-bio\">Lizzy leads STAT\u2019s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency\u2019s ability to protect and promote public health. Confidential tips can be sent on Signal at lizzylaw.53.<\/p>\n<p>WASHINGTON \u2014 Federal health officials announced a pilot program Monday to speed up early-stage clinical trials, which they say will reduce development timelines by six to 12 months, in hopes of encouraging U.S.-based trials and combating <a href=\"https:\/\/www.statnews.com\/2026\/05\/18\/biotech-industry-split-chinese-drugs-opportunity-versus-existential-threat\/\" rel=\"nofollow noopener\" target=\"_blank\">Chinese dominance in the field<\/a>.<\/p>\n<p>The pilot comes as the Food and Drug Administration, through the president\u2019s 2027 fiscal budget, asks Congress to establish a permanent, faster process for the existing Investigational New Drug pathway. That proposal was championed by former FDA Commissioner Marty Makary before <a href=\"https:\/\/www.statnews.com\/2026\/05\/12\/fda-commissioner-marty-makary-resigns-kyle-diamantas-acting\/\" rel=\"nofollow noopener\" target=\"_blank\">he resigned last month<\/a>, though officials said on a Monday morning call that this program had been in the works since the start of the administration.<\/p>\n<p>In a Fox News op-ed, health secretary Robert F. Kennedy Jr. <a href=\"https:\/\/www.foxnews.com\/opinion\/robert-f-kennedy-jr-future-medicine-built-america\" target=\"_blank\" rel=\"noopener nofollow\">wrote that the U.S.<\/a> is \u201closing ground\u201d against China in clinical research and touted the actions as a way to reverse that trend.<\/p>\n<p class=\"restricted-text\">STAT+ Exclusive Story<\/p>\n<p class=\"restricted-login\">Already have an account? <a href=\"https:\/\/www.statnews.com\/login\/\" data-stat-login=\"\" data-stat-paywall-cta=\"breaker login cta\" rel=\"nofollow noopener\" target=\"_blank\">Log in<\/a><\/p>\n<p>\t\t\t<img decoding=\"async\" class=\"restricted-content-breaker-bg\" src=\"https:\/\/www.newsbeep.com\/us\/wp-content\/uploads\/2025\/12\/1765280600_844_stat-plus-breaker-bg.png\" alt=\"STAT+\"\/><\/p>\n<p>\t\t\t\t\t<a href=\"https:\/\/www.statnews.com\/stat-plus\/\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"stat-plus-logo\" src=\"https:\/\/www.statnews.com\/wp-content\/themes\/stat\/images\/stat-plus-logo-white.svg\" alt=\"STAT+\"\/><br \/>\n\t\t\t\t\t<\/a><\/p>\n<p>\t\t\t\tThis article is exclusive to STAT+ subscribers<br \/>\n\t\t\t\tUnlock this article \u2014 plus daily coverage and analysis of the biotech sector \u2014 by subscribing to STAT+.<\/p>\n<p class=\"restricted-content-breaker-wrapper-cta mobile\">Already have an account? <a href=\"https:\/\/www.statnews.com\/login\/\" data-stat-login=\"\" data-stat-paywall-cta=\"breaker login cta mobile\" rel=\"nofollow noopener\" target=\"_blank\">Log in<\/a><\/p>\n<p>\t\t\t\t\t\tIndividual plans<\/p>\n<p>\t\t\t\t\t\tGroup plans<\/p>\n<p>\t\t\t\t<a href=\"https:\/\/www.statnews.com\/stat-plus\/\" class=\"stat-button view-all\" data-stat-paywall-cta=\"breaker view all plans\" aria-label=\"View All Plans\" rel=\"nofollow noopener\" target=\"_blank\">View All Plans<\/a><\/p>\n<p class=\"restricted-content-text\">\n\t\t\t\t\t\tTo read the rest of this story subscribe to STAT+.\t\t\t\t\t<\/p>\n<p>\t\t\t\t\t<a href=\"https:\/\/www.statnews.com\/stat-plus\/\" class=\"stat-button restricted-button\" data-stat-paywall-cta=\"breaker subscribe cta 1\" rel=\"nofollow noopener\" target=\"_blank\">Subscribe<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Lizzy leads STAT\u2019s coverage of the FDA. Her stories explore the relationship between politics and science at the&hellip;\n","protected":false},"author":2,"featured_media":719822,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27],"tags":[244,28,47844,245,246,10791,247,1343,1728,248],"class_list":["post-719821","post","type-post","status-publish","format-standard","has-post-thumbnail","category-business","tag-biotechnology","tag-business","tag-clinical-trials","tag-drug-development","tag-fda","tag-hhs","tag-pharmaceuticals","tag-policy","tag-research","tag-stat"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/719821","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=719821"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/719821\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/719822"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=719821"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=719821"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=719821"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}